332 related articles for article (PubMed ID: 27352189)
1. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
Urbanska AM; Zhang X; Prakash S
Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
3. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
[TBL] [Abstract][Full Text] [Related]
4. Host-microbiota interaction and intestinal stem cells in chronic inflammation and colorectal cancer.
Moossavi S; Zhang H; Sun J; Rezaei N
Expert Rev Clin Immunol; 2013 May; 9(5):409-22. PubMed ID: 23634736
[TBL] [Abstract][Full Text] [Related]
5. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.
Algieri F; Zorrilla P; Rodriguez-Nogales A; Garrido-Mesa N; Bañuelos O; González-Tejero MR; Casares-Porcel M; Molero-Mesa J; Zarzuelo A; Utrilla MP; Rodriguez-Cabezas ME; Galvez J
J Ethnopharmacol; 2013 Apr; 146(3):750-9. PubMed ID: 23395625
[TBL] [Abstract][Full Text] [Related]
6. Eicosanoid pathway in colorectal cancer: Recent updates.
Tuncer S; Banerjee S
World J Gastroenterol; 2015 Nov; 21(41):11748-66. PubMed ID: 26557000
[TBL] [Abstract][Full Text] [Related]
7. Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy.
Ma S; Yao H; Si X; Huang Z; Wang R; Wan R; Tang Z; Wang G; Song W
J Control Release; 2024 Jun; 370():528-542. PubMed ID: 38705520
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory phytochemicals for chemoprevention of colon cancer.
Madka V; Rao CV
Curr Cancer Drug Targets; 2013 Jun; 13(5):542-57. PubMed ID: 23597198
[TBL] [Abstract][Full Text] [Related]
9. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
Ryan BM; Russel MG; Langholz E; Stockbrugger RW
Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319
[TBL] [Abstract][Full Text] [Related]
10. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
11. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
13. The role of inflammation in colon cancer.
Janakiram NB; Rao CV
Adv Exp Med Biol; 2014; 816():25-52. PubMed ID: 24818718
[TBL] [Abstract][Full Text] [Related]
14. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
[TBL] [Abstract][Full Text] [Related]
15. The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer.
Park JH; McMillan DC; Horgan PG; Roxburgh CS
Cancer Treat Rev; 2014 Feb; 40(1):68-77. PubMed ID: 23773805
[TBL] [Abstract][Full Text] [Related]
16. Microbiome, inflammation and colorectal cancer.
Chen J; Pitmon E; Wang K
Semin Immunol; 2017 Aug; 32():43-53. PubMed ID: 28982615
[TBL] [Abstract][Full Text] [Related]
17. The gastrointestinal microbiota and colorectal cancer.
Keku TO; Dulal S; Deveaux A; Jovov B; Han X
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G351-63. PubMed ID: 25540232
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
Chan EP; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Sep; 35(3):675-712. PubMed ID: 16952746
[TBL] [Abstract][Full Text] [Related]
19. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
Frigerio S; Lartey DA; D'Haens GR; Grootjans J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs and Inflammation in Colorectal Cancer.
Josse C; Bours V
Adv Exp Med Biol; 2016; 937():53-69. PubMed ID: 27573894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
